Research Applications of Sildigra 50mg
Sildigra 50mg is a sildenafil citrate formulation manufactured by Dharam Distributors, designed for investigating phosphodiesterase-5 (PDE5) enzyme inhibition mechanisms in controlled laboratory environments. This compound belongs to the class of PDE5 inhibitors and serves as a valuable research tool for examining nitric oxide signalling pathways and cyclic guanosine monophosphate (cGMP) regulation in vascular biology studies. Researchers at Stroid UK Shop can access this formulation alongside comprehensive analytical documentation for their experimental protocols.
Molecular Mechanisms in Laboratory Investigation
In preclinical research models, sildenafil citrate demonstrates selective inhibition of the PDE5 enzyme, which is responsible for degrading cGMP in smooth muscle cells. This inhibition leads to increased cGMP levels, resulting in smooth muscle relaxation and vasodilation in experimental tissue preparations. Research applications focus on understanding the role of PDE5 in various physiological processes, including vascular reactivity, platelet aggregation, and smooth muscle contractility. Studies examine how PDE5 inhibition affects nitric oxide bioavailability and endothelial function in isolated vessel preparations. Investigators studying cardiovascular pharmacology often utilise this compound to examine sildenafil-based research compounds for their experimental designs. The compound’s well-characterised pharmacokinetic profile makes it suitable for dose-response studies and mechanistic investigations in laboratory settings.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Sildenafil Citrate |
| Strength per Unit | 50mg |
| Manufacturer | Dharam Distributors |
| CAS Number | 139755-83-2 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.70 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Product Code | EU15016 |
Research laboratories studying metabolic pathways may also explore related compounds available through our selective androgen receptor modulator collection or investigate complementary signalling mechanisms using our peptide research compounds for comprehensive experimental approaches.
Laboratory Compliance and Research Use
This product is manufactured specifically for in-vitro research applications and laboratory investigation purposes only. Sildigra 50mg is not intended for human consumption, therapeutic use, or any applications outside of controlled scientific research environments. All purchases must comply with applicable research regulations and institutional review board requirements. Proper laboratory safety protocols, including appropriate personal protective equipment and containment procedures, should be implemented when handling this compound. Research institutions should maintain detailed records of compound usage and disposal according to standard laboratory practices and local regulatory guidelines.
